rs80354176
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001127198.5(TMC6):āc.704A>Gā(p.Lys235Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0016 in 1,596,534 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0020 ( 6 hom., cov: 33)
Exomes š: 0.0016 ( 60 hom. )
Consequence
TMC6
NM_001127198.5 missense
NM_001127198.5 missense
Scores
2
10
6
Clinical Significance
Conservation
PhyloP100: 5.29
Genes affected
TMC6 (HGNC:18021): (transmembrane channel like 6) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 10 transmembrane domains and 2 leucine zipper motifs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0045574605).
BP6
Variant 17-78124711-T-C is Benign according to our data. Variant chr17-78124711-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 456016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78124711-T-C is described in Lovd as [Benign].
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0504 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMC6 | NM_001127198.5 | c.704A>G | p.Lys235Arg | missense_variant | 8/20 | ENST00000590602.6 | NP_001120670.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMC6 | ENST00000590602.6 | c.704A>G | p.Lys235Arg | missense_variant | 8/20 | 2 | NM_001127198.5 | ENSP00000465261.1 |
Frequencies
GnomAD3 genomes AF: 0.00200 AC: 305AN: 152190Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
305
AN:
152190
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00504 AC: 1080AN: 214148Hom.: 41 AF XY: 0.00458 AC XY: 534AN XY: 116618
GnomAD3 exomes
AF:
AC:
1080
AN:
214148
Hom.:
AF XY:
AC XY:
534
AN XY:
116618
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00156 AC: 2248AN: 1444226Hom.: 60 Cov.: 33 AF XY: 0.00151 AC XY: 1085AN XY: 717038
GnomAD4 exome
AF:
AC:
2248
AN:
1444226
Hom.:
Cov.:
33
AF XY:
AC XY:
1085
AN XY:
717038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00200 AC: 304AN: 152308Hom.: 6 Cov.: 33 AF XY: 0.00215 AC XY: 160AN XY: 74470
GnomAD4 genome
AF:
AC:
304
AN:
152308
Hom.:
Cov.:
33
AF XY:
AC XY:
160
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
491
Asia WGS
AF:
AC:
63
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Epidermodysplasia verruciformis, susceptibility to, 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 23, 2021 | - - |
Epidermodysplasia verruciformis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D;D;D;D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;N;N;N;.;.
REVEL
Uncertain
Sift
Pathogenic
.;D;D;D;.;.
Sift4G
Uncertain
D;D;D;D;D;.
Polyphen
D;D;D;D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at